Wajnat A Tounsi, Osama A Alzahrani, Ahmed G Bukhari, Raed M Garout, Raed I Felimban, Ruqaia H Al-Musallam, Waleed M Bawazir, Hadeel Al Sadoun, Majed R Algarni, Walaa H AlAmoudi, Nawaf M Alomayri, Mohammed A Labban, Sara S Alghamdi, Nora Y Hakami
{"title":"通过有针对性的干预措施减少血液成分的浪费:在沙特一家三级医院进行的一项为期四年的回顾性研究。","authors":"Wajnat A Tounsi, Osama A Alzahrani, Ahmed G Bukhari, Raed M Garout, Raed I Felimban, Ruqaia H Al-Musallam, Waleed M Bawazir, Hadeel Al Sadoun, Majed R Algarni, Walaa H AlAmoudi, Nawaf M Alomayri, Mohammed A Labban, Sara S Alghamdi, Nora Y Hakami","doi":"10.1111/tme.70015","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Blood transfusion services are vital to healthcare; however, blood component wastage remains a persistent challenge for transfusion facilities, impacting resource efficiency and patient care. In this four-year retrospective before-and-after study, we investigated blood component wastage at a tertiary hospital in Saudi Arabia to identify key causes of wastage and evaluate the impact of targeted interventions introduced in 2024.</p><p><strong>Methods: </strong>Statistical analyses included z-tests for rate comparisons, effect size estimation using Cohen's h, and 95% confidence intervals (CIs) to assess the impact of the interventions.</p><p><strong>Results: </strong>From 2021 to 2024, 83,185 components were prepared and 13,954 units were discarded. Between 2021 and 2023, the average waste rate was 19.44%. Leading causes included expiration (28.40%), TTI screening reactivity (20.11%), and low platelet yield (18.39%). Following the 2024 implementation of targeted measures-including improved inventory policies, donor screening, and transfusion practices-total waste declined by 35.71% (p < 0.001, 95% CI: 0.016 to 0.024), with a moderate effect size (Cohen's h = 0.20). Total monthly waste rates were also significantly reduced (mean difference of 7.73 percentage points; p < 0.001, 95% CI: 4.87% to 10.59%, Cohen's d = 2.29). The WAPI scores improved across all components, and associated costs were reduced by 15.9%, saving approximately SAR 171366 (US$45856).</p><p><strong>Conclusion: </strong>These findings demonstrate the effectiveness of interventions for reducing blood component wastage and enhancing transfusion service efficiency. Ongoing monitoring and continuous quality improvement are essential to sustain these outcomes and further optimize transfusion practices.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reducing blood component wastage through targeted interventions: A four-year retrospective study at a Saudi tertiary hospital.\",\"authors\":\"Wajnat A Tounsi, Osama A Alzahrani, Ahmed G Bukhari, Raed M Garout, Raed I Felimban, Ruqaia H Al-Musallam, Waleed M Bawazir, Hadeel Al Sadoun, Majed R Algarni, Walaa H AlAmoudi, Nawaf M Alomayri, Mohammed A Labban, Sara S Alghamdi, Nora Y Hakami\",\"doi\":\"10.1111/tme.70015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Blood transfusion services are vital to healthcare; however, blood component wastage remains a persistent challenge for transfusion facilities, impacting resource efficiency and patient care. In this four-year retrospective before-and-after study, we investigated blood component wastage at a tertiary hospital in Saudi Arabia to identify key causes of wastage and evaluate the impact of targeted interventions introduced in 2024.</p><p><strong>Methods: </strong>Statistical analyses included z-tests for rate comparisons, effect size estimation using Cohen's h, and 95% confidence intervals (CIs) to assess the impact of the interventions.</p><p><strong>Results: </strong>From 2021 to 2024, 83,185 components were prepared and 13,954 units were discarded. Between 2021 and 2023, the average waste rate was 19.44%. Leading causes included expiration (28.40%), TTI screening reactivity (20.11%), and low platelet yield (18.39%). Following the 2024 implementation of targeted measures-including improved inventory policies, donor screening, and transfusion practices-total waste declined by 35.71% (p < 0.001, 95% CI: 0.016 to 0.024), with a moderate effect size (Cohen's h = 0.20). Total monthly waste rates were also significantly reduced (mean difference of 7.73 percentage points; p < 0.001, 95% CI: 4.87% to 10.59%, Cohen's d = 2.29). The WAPI scores improved across all components, and associated costs were reduced by 15.9%, saving approximately SAR 171366 (US$45856).</p><p><strong>Conclusion: </strong>These findings demonstrate the effectiveness of interventions for reducing blood component wastage and enhancing transfusion service efficiency. Ongoing monitoring and continuous quality improvement are essential to sustain these outcomes and further optimize transfusion practices.</p>\",\"PeriodicalId\":23306,\"journal\":{\"name\":\"Transfusion Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transfusion Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/tme.70015\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/tme.70015","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Reducing blood component wastage through targeted interventions: A four-year retrospective study at a Saudi tertiary hospital.
Background: Blood transfusion services are vital to healthcare; however, blood component wastage remains a persistent challenge for transfusion facilities, impacting resource efficiency and patient care. In this four-year retrospective before-and-after study, we investigated blood component wastage at a tertiary hospital in Saudi Arabia to identify key causes of wastage and evaluate the impact of targeted interventions introduced in 2024.
Methods: Statistical analyses included z-tests for rate comparisons, effect size estimation using Cohen's h, and 95% confidence intervals (CIs) to assess the impact of the interventions.
Results: From 2021 to 2024, 83,185 components were prepared and 13,954 units were discarded. Between 2021 and 2023, the average waste rate was 19.44%. Leading causes included expiration (28.40%), TTI screening reactivity (20.11%), and low platelet yield (18.39%). Following the 2024 implementation of targeted measures-including improved inventory policies, donor screening, and transfusion practices-total waste declined by 35.71% (p < 0.001, 95% CI: 0.016 to 0.024), with a moderate effect size (Cohen's h = 0.20). Total monthly waste rates were also significantly reduced (mean difference of 7.73 percentage points; p < 0.001, 95% CI: 4.87% to 10.59%, Cohen's d = 2.29). The WAPI scores improved across all components, and associated costs were reduced by 15.9%, saving approximately SAR 171366 (US$45856).
Conclusion: These findings demonstrate the effectiveness of interventions for reducing blood component wastage and enhancing transfusion service efficiency. Ongoing monitoring and continuous quality improvement are essential to sustain these outcomes and further optimize transfusion practices.
期刊介绍:
Transfusion Medicine publishes articles on transfusion medicine in its widest context, including blood transfusion practice (blood procurement, pharmaceutical, clinical, scientific, computing and documentary aspects), immunohaematology, immunogenetics, histocompatibility, medico-legal applications, and related molecular biology and biotechnology.
In addition to original articles, which may include brief communications and case reports, the journal contains a regular educational section (based on invited reviews and state-of-the-art reports), technical section (including quality assurance and current practice guidelines), leading articles, letters to the editor, occasional historical articles and signed book reviews. Some lectures from Society meetings that are likely to be of general interest to readers of the Journal may be published at the discretion of the Editor and subject to the availability of space in the Journal.